Invention Title:

SYSTEMS AND METHODS FOR PREVENTING, MITIGATING, AND/OR TREATING DEMENTIA VIA VISUAL STIMULATION THAT BINDS HIGHER ORDER BRAIN REGIONS, REDUCES NEURODEGENERATION AND NEUROINFLAMMATION, AND IMPROVES COGNITIVE FUNCTION

Publication number:

US20260325868

Publication date:
Section:

Human necessities

Class:

A61N5/0622

Inventors:

Assignee:

Applicant:

Smart overview of the Invention

The patent application describes a system and method for treating dementia and Alzheimer's disease through non-invasive visual stimulation. The approach involves delivering visual stimuli at frequencies between 30 Hz and 50 Hz, particularly around 40 Hz, to entrain gamma oscillations in the brain. This method targets multiple brain regions, including the prefrontal cortex and hippocampus, to modulate neuronal activity and induce neuroprotective effects, such as reducing amyloid plaques and tau hyper-phosphorylation, which are associated with neurodegeneration.

Mechanism

The visual stimulation aims to synchronize gamma oscillations across various brain regions, which facilitates the functional binding of neural networks. This synchronization is believed to reduce neuroinflammation by modulating the activity of microglia and correcting aberrantly modified genes and proteins involved in critical cellular processes. The method shows promise in enhancing learning and memory, suggesting improvements in cognitive function for individuals with dementia or Alzheimer's disease.

Innovative Implementations

Several implementations of the method are proposed:

  • Delivering chronic visual stimuli to entrain synchronized gamma oscillations in the prefrontal cortex and hippocampus.
  • Ameliorating aberrantly modified genes and proteins in degenerating neurons through gamma oscillation entrainment.
  • Increasing gamma coherence across multiple brain regions to enhance cognitive functions.

These implementations focus on non-invasive techniques to achieve therapeutic outcomes in dementia treatment.

Research Background

Research indicates that gamma frequency oscillations are reduced in Alzheimer's patients and related mouse models. Previous studies demonstrated that enhancing these oscillations can alleviate symptoms and reduce amyloid load. The current application builds on these findings by proposing a method that extends the benefits of gamma entrainment to multiple brain regions, thereby offering a comprehensive approach to neuroprotection and cognitive enhancement.

Conclusion

The patent application highlights the potential of using visual stimuli to treat dementia and Alzheimer's disease by targeting synchronized gamma oscillations in the brain. This method offers a non-invasive solution that could significantly impact the treatment of neurodegenerative diseases by improving cognitive functions and reducing pathological markers. The detailed description and examples provided aim to guide further research and development in this promising field.